The latest clinical guidelines from the American College of Gastroenterology aim to improve the diagnosis and treatment of ...

Adults younger than 65 years with esophageal cancer were extremely unlikely to have a previous diagnosis of eosinophilic ...

The "Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of ...

Long-term budesonide orodispersible tablets effectively maintained remission in patients with eosinophilic esophagitis and demonstrated a favorable safety profile.

The Eosinophilic Esophagitis market report provides current treatment practices, emerging drugs, Eosinophilic Esophagitis market share of individual therapies, and current and forecasted ...

Topical steroids taken daily or twice daily do not result in significantly varying outcomes among individuals with eosinophilic esophagitis.

IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs for Inflammation have a 44% phase transition ...

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops, and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, ...